TXNIP and diabetes mellitus: As reviewed elsewhere, glucose-induced higher tissue TXNIP expression has become a relevant therapeutic target not only to improve insulin secretion and sensitivity, but also for ameliorating the long-term microvascular and macrovascular complications of diabetes [67,145,178,179,180,181].